Celgene has also filed for approval of the R² regimen for these indolent forms of NHL in Europe and Japan, with an EMA verdict possible before the end of the year. Image Phil Taylor ...

Celgene's European leader Tuomo Pätsi talks to pharmaphorum about the firm's remarkable growth, which is set to continue thanks to myeloma blockbuster Revlimid and new psoriasis and psoriatic ...

After hours: March 11 at 7:55:35 PM EDT Loading Chart for AR ...

Thank you for reporting this station. We will review the data in question. You are about to report this weather station for bad data. Please select the information that is incorrect.

Thank you for reporting this station. We will review the data in question. You are about to report this weather station for bad data. Please select the information that is incorrect.